ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.


Journal

Brachytherapy
ISSN: 1873-1449
Titre abrégé: Brachytherapy
Pays: United States
ID NLM: 101137600

Informations de publication

Date de publication:
Historique:
received: 09 12 2020
accepted: 22 01 2021
pubmed: 8 4 2021
medline: 12 10 2021
entrez: 7 4 2021
Statut: ppublish

Résumé

The American College of Radiology (ACR), American Brachytherapy Society (ABS), American College of Nuclear Medicine (ACNM), American Society for Radiation Oncology (ASTRO), Society of Interventional Radiology (SIR), and Society of Nuclear Medicine and Molecular Imaging (SNMMI) have jointly developed a practice parameter on selective internal radiation therapy (SIRT) or radioembolization for treatment of liver malignancies. Radioembolization is the embolization of the hepatic arterial supply of hepatic primary tumors or metastases with a microsphere yttrium-90 brachytherapy device. The ACR -ABS -ACNM -ASTRO -SIR -SNMMI practice parameter for SIRT or radioembolization for treatment of liver malignancies was revised in accordance with the process described on the ACR website (https://www.acr.org/ClinicalResources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters-Interventional and Cardiovascular Radiology of the ACR Commission on Interventional and Cardiovascular, Committee on Practice Parameters and Technical Standards-Nuclear Medicine and Molecular Imaging of the ACR Commission on Nuclear Medicine and Molecular Imaging and the Committee on Practice Parameters-Radiation Oncology of the ACR Commission on Radiation Oncology in collaboration with ABS, ACNM, ASTRO, SIR, and SNMMI. This practice parameter is developed to serve as a tool in the appropriate application of radioembolization in the care of patients with conditions where indicated. It addresses clinical implementation of radioembolization including personnel qualifications, quality assurance standards, indications, and suggested documentation. This practice parameter is a tool to guide clinical use of radioembolization. It focuses on the best practices and principles to consider when using radioemboliozation effectively. The clinical benefit and medical necessity of the treatment should be tailored to each individual patient.

Identifiants

pubmed: 33824051
pii: S1538-4721(21)00006-4
doi: 10.1016/j.brachy.2021.01.006
pii:
doi:

Substances chimiques

Yttrium Radioisotopes 0

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-511

Informations de copyright

Copyright © 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Kelvin Hong (K)

Department of Radiation Oncology, Johns Hopkins Medicine, Baltimore, MD. Electronic address: khong1@jhmi.edu.

Olaguoke Akinwande (O)

Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO.

Lisa Bodei (L)

Memorial Sloan Kettering Cancer Center, New York, NY.

Murthy Rk Chamarthy (MR)

Department of Radiology, Vascular Institute of North Texas, Bedford, TX.

Phillip M Devlin (PM)

Department of Radiation Oncology, Harvard Medical School, Brigham and Womens Hospital, Boston, MA.

Shana Elman (S)

University of New Mexico Medical Center, Albuquerque, NM.

Suvranu Ganguli (S)

Department of Interventional Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA.

Andrew S Kennedy (AS)

Department of Radiation Oncology, Sarah Cannon Research Institute, Sarah Cannon, Nashville, TN.

Sonya J Koo (SJ)

Department of Radiology, University of California San Diego, La Jolla, CA.

Zoubir Ouhib (Z)

Department of Radiation Oncology, Florida Atlantic University, Boca Raton Community Hospital, Boca Raton, FL.

Siddharth A Padia (SA)

Department of Radiology, UCLA, Los Angeles, CA.

Riad Salem (R)

Department of Radiology, Northwestern University, Northwestern Medicine, Chicago, IL.

Reed G Selwyn (RG)

Department of Radiology, University of New Mexico, SNMMI, Albuquerque, NM.

Catheryn M Yashar (CM)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.

Don C Yoo (DC)

Department of Radiology, Rhode Island Medical Imaging, Providence, RI.

Bassem I Zaki (BI)

Department of Radiation Oncology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Hanover, NH.

Alan C Hartford (AC)

Dartmouth-Hitchcock Medical Center, Section of Radiation Oncology, Lebanon, NH.

Clayton K Trimmer (CK)

Department of Radiology, American Radiology Association, Baylor University Medical Center, Dallas, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH